Vitamin B12 effectiveness in the management of hospitalized COVID‐19 and its clinical outcomes and complications: A randomized clinical trial
Open Access
- 14 September 2023
- journal article
- research article
- Published by Wiley in Health Science Reports
- Vol. 6 (9) , e1509
Abstract
Background and Aims: Since 2019, severe acute respiratory syndrome coronavirus 2, has spread and challenged the health care system for treatment which is mainly limited to supportive care. It is well‐established that malnutrition impedes the immunity in human bodies, and makes it vulnerable to microorganisms. Vitamin B12 is one of the agents that has critical roles in body systems. Thus, the following clinical trial was conducted to assess its possible therapeutic value in COVID‐19 patients.Method: The present randomized clinical trial was carried out in Baharlou Hospital, and patients with confirmed COVID‐19 infection within 24 h of admission were included. We used quadruple blocks randomization to divide patients into groups of case and control. The case group received 1000 mg of vitamin B12, daily for 7 day while the patients in control group were administered distilled water as placebo. The studied outcomes were duration of hospitalization, need for intensive care unit (ICU), mechanical ventilation, mortality rate and laboratory findings. The statistical analysis was done via SPSS version 22.Results: After implementing inclusion and exclusion criteria, 34 participants were included in the study, 20 of which were male. Serum levels of creatinine, LDH (Lactate dehydrogenase), Ferritin, and CRP (C‐reactive protein) had decreased in both groups. The improving changes of CRP, LDH, ferritin and creatinine was higher in case group. The increase of Alanine Transaminase and D‐dimer was higher in control group. however there was no statistically significant difference. More patients were admitted to ICU in the control group but the difference was not statistically significant. Duration of hospitalization did not differ statistically between the groups. No in hospital mortality has been recorded.Conclusion: Our study suggests that vitamin B12 supplementation seem to have curative effect in COVID‐19. Nutritious diet is necessary for proper functioning of the immune system. Since malnutrition is associated with poor prognosis in COVID‐19 patients, and limited number of participants in this study, we suggest performing meta‐analysis on similar studies to reach reliable result.Keywords
This publication has 25 references indexed in Scilit:
- Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19)Nutrition, 2020
- How the Covid-19 epidemic is challenging our practice in clinical nutrition—feedback from the fieldEuropean Journal of Clinical Nutrition, 2020
- Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic FrameworkNutrients, 2020
- Nutritional status of micronutrients as a possible and modifiable risk factor for COVID-19: a UK perspectiveBritish Journal of Nutrition, 2020
- Nutrients in prevention, treatment, and management of viral infections; special focus on CoronavirusArchives of Physiology and Biochemistry, 2020
- Factors Associated with Mortality in COVID-19 Patients: A Systematic Review and Meta-AnalysisIranian Journal of Public Health, 2020
- Can vitamin B12 be an adjuvant to COVID-19 treatment?GSC Biological and Pharmaceutical Sciences, 2020
- Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, ChinaEuropean Journal of Clinical Nutrition, 2020
- Folate and vitamin B12 status and their relation to hematological indices in healthy adults of Iranians: Azar cohort studyNutrition and Health, 2018
- Prevalence of Vitamin Deficiencies on Admission: Relationship to Hospital Mortality in Critically Ill PatientsAnaesthesia and Intensive Care, 2009